...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details

Masila

Thanks for the herculean effort !

Chicagoest

Share
New Message
Please login to post a reply